DK0697876T3 - Xenograftthymus - Google Patents

Xenograftthymus

Info

Publication number
DK0697876T3
DK0697876T3 DK94917424T DK94917424T DK0697876T3 DK 0697876 T3 DK0697876 T3 DK 0697876T3 DK 94917424 T DK94917424 T DK 94917424T DK 94917424 T DK94917424 T DK 94917424T DK 0697876 T3 DK0697876 T3 DK 0697876T3
Authority
DK
Denmark
Prior art keywords
thymus
xenograft
donor
engraftment
proliferation
Prior art date
Application number
DK94917424T
Other languages
Danish (da)
English (en)
Inventor
Megan Sykes
David H Sachs
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Application granted granted Critical
Publication of DK0697876T3 publication Critical patent/DK0697876T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Glass Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Prostheses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK94917424T 1993-05-17 1994-05-16 Xenograftthymus DK0697876T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6294693A 1993-05-17 1993-05-17
US16391293A 1993-12-07 1993-12-07
PCT/US1994/005528 WO1994026285A1 (en) 1993-05-17 1994-05-16 Xenograft thymus

Publications (1)

Publication Number Publication Date
DK0697876T3 true DK0697876T3 (da) 2002-09-09

Family

ID=26742900

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94917424T DK0697876T3 (da) 1993-05-17 1994-05-16 Xenograftthymus

Country Status (10)

Country Link
EP (1) EP0697876B1 (de)
JP (1) JP3553941B2 (de)
AT (1) ATE222111T1 (de)
AU (1) AU694120B2 (de)
CA (1) CA2161797A1 (de)
DE (1) DE69431184T2 (de)
DK (1) DK0697876T3 (de)
ES (1) ES2179846T3 (de)
PT (1) PT697876E (de)
WO (1) WO1994026285A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040018302A (ko) * 2000-10-13 2004-03-03 모나쉬 유니버시티 흉선 재생의 조작을 통한 이식체 수용능의 개선
AP2003002796A0 (en) * 2000-10-13 2003-06-30 Richard Boyd Disease prevention by reactivation of the thymus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087570A (en) * 1988-05-10 1992-02-11 Weissman Irving L Homogeneous mammalian hematopoietic stem cell composition

Also Published As

Publication number Publication date
PT697876E (pt) 2002-11-29
DE69431184D1 (en) 2002-09-19
WO1994026285A1 (en) 1994-11-24
ATE222111T1 (de) 2002-08-15
EP0697876B1 (de) 2002-08-14
AU6915794A (en) 1994-12-12
EP0697876A1 (de) 1996-02-28
CA2161797A1 (en) 1994-11-24
JPH09500364A (ja) 1997-01-14
EP0697876A4 (de) 1997-09-10
JP3553941B2 (ja) 2004-08-11
DE69431184T2 (de) 2003-03-27
AU694120B2 (en) 1998-07-16
ES2179846T3 (es) 2003-02-01

Similar Documents

Publication Publication Date Title
GEP20022648B (en) Method for Inducing T Cell Tolerance to a Tissue or Organ Graft
DK1131065T3 (da) Diakyldumarater til behandling af autoimmunsygdomme
ES2170096T3 (es) Uso de lineas celulares fetales neuroderivadas para terapia de trasplantes.
DK1063945T3 (da) Tvedelt prostetisk graft
AR009560A1 (es) Prolongacion de la sobrevida de injertos con porfirinas
ES2167332T3 (es) Procedimiento y sistemas para el implante de celulas vivas en organismos huespedes.
ES2177565T3 (es) Cojinete de casquillo acetabular bloqueado conico.
ES2179077T3 (es) Acido glutamico decarboxilasa clonada.
NZ227787A (en) Peptides and compositions having growth hormone regulatory effects
FI930883A7 (fi) Aktiivisten tekijöiden in vivo -annostelu keraviljeltyjen solusiirränn äisten avulla
DK0914144T3 (da) Terapeutiske anvendelser af BPI-protein-produkter til human meningokokæmi
BR9306345A (pt) Métodos para suprimir a habilidade de células-t de um mamífero de proliferar e para suprimir resposta imune composições para uso na supressão da capacidade de células-t de proliferarem e na supressão de resposta imune
DE3875306D1 (de) Immunosuppression bei der auf immunotoxin basierten behandlung von menschen.
DK0697876T3 (da) Xenograftthymus
IL131478A0 (en) Methods for treatment of scar tissue
EP1637146A3 (de) Ex vivo behandlung von allogenen und xenogenen t-zellen mit gp39-antagonisten
PT925064E (pt) 5-androsteno-3beta,17alfa-diol como um inibidor do crescimento tumoral
EP0668771A4 (de) Behandlung von autoimmunkrankheiten durch hervorrüfen von toleranz in zellen, geweben und organen.
EP1048298A3 (de) Gemischter Chimerismus und Toleranz
ATE217180T1 (de) Urne für aschen von verstorbenen
RU93025273A (ru) Способ закрытия обширных дефектов кожи черепа
ES2107377A1 (es) Protesis de disco intervertebral.
AU130339S (en) Meditation pyramid
UA28362A (uk) Спосіб лікування цукрового діабету в експерименті
IT1254742B (it) Impiego della beta-endorfina quale farmaco immunosoppressore nei trapianti d'organo